What are ledipasvir and sofosbuvir tablets used for?
Adults and children 3 years of age and older take a combination of ledipasvir and sofosbuvir with or without ribavirin to treat chronic hepatitis C infection (including liver transplant patients, with or without cirrhosis).
Does Sofocure-L work?
These medications operate by decreasing the amount of the hepatitis C virus in your body, which aids your immune system in fighting the infection and may aid liver recovery. Chronic hepatitis C infection can lead to major liver disorders like scarring (cirrhosis) and malignancy.
What does Sofocure-L do?
It works by lowering the body’s hepatitis C virus (HCV) levels. HCV NS5A inhibitors, such as ledipasvir, belong to a class of antiviral drugs known as HCV NS5A inhibitors. It works by blocking the spread of the hepatitis C virus inside the body.
What is the mode of action of Sofocure-L?
The medication is a direct-acting antiviral that inhibits viral replication by interfering with the HCV lifecycle. It works as a chain terminator and can be integrated into HCV RNA by the NS5B polymerase. The medication is available as 400mg tablets for oral use.
What type of drug is Sofocure-L?
It belongs to the nucleotide polymerase inhibitors class of antiviral drugs. It works by lowering the body’s hepatitis C virus (HCV) levels.
Which common drug should be avoided when taking Sofocure-L?
If you take Sofocure-L with amiodarone, your heart may experience serious adverse effects.
How long do you take Sofocure-L?
For oral administration (tablets): Infection with the hepatitis C virus: Adults should take one pill once a day for 12 weeks. Sofosbuvir 400 mg and velpatasvir 100 mg are found in each pill. To know more click here.
Does Sofocure-L cure hep C?
It is effective for treating HCV genotypes 1, 2, 3, and 4, and in clinical studies, the medicine eliminated the hepatitis C virus from the blood of 50 percent to 90 percent of those who took it.
Is sofosbuvir a direct-acting antiviral?
Direct-acting antiviral medication based on sofosbuvir has changed the treatment of hepatitis C virus (HCV) infection.